Lexeo Therapeutics, Inc. — Investor Relations & Filings
Lexeo Therapeutics, Inc. is a clinical-stage genetic medicine company dedicated to developing gene therapies for genetically defined diseases. The company is advancing a diverse pipeline of investigational adeno-associated virus (AAV)-based gene therapy candidates. Its primary areas of focus are rare cardiovascular diseases and APOE4-associated Alzheimer's disease. Lexeo's strategy centers on addressing conditions with high unmet medical needs by leveraging pioneering science, including research originating from institutions such as Weill Cornell Medicine, to develop treatments with curative potential.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-05-11 | English | |
| 8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-05-11 | English | |
| ARS - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-04-30 | English | |
| DEF 14A - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-04-30 | English | |
| 8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-04-30 | English | |
| 10-K - Lexeo Therapeutics, Inc. (0001907108) (Filer) | 2026-03-30 | English |
Browse filings by year
5 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Gemina Laboratories Ltd.
Biotechnology company developing IVD and biosensing solutio…
|
GLAB | CA | Manufacturing |
|
GemVax & KAEL Co.,Ltd.
Clinical-stage biopharma developing therapeutics for neurod…
|
082270 | KR | Manufacturing |
|
Gencurix Inc.
Develops and commercializes diagnostic solutions for precis…
|
229000 | KR | Manufacturing |
|
GENEDRIVE PLC
Develops rapid, point-of-care pharmacogenetic testing platf…
|
GDR | GB | Manufacturing |
|
GENELUX Corp
Clinical-stage biopharma developing oncolytic viral immunot…
|
GNLX | US | Manufacturing |
|
GENEMATRIX INC.
Develops multiplex PCR diagnostic products for infectious d…
|
109820 | KR | Manufacturing |
|
Generation Bio Co.
Develops siRNA therapeutics delivered via ctLNPs for T cell…
|
GBIO | US | Manufacturing |
|
GENETIC SIGNATURES LIMITED
Molecular diagnostics company using proprietary 3base techn…
|
GSS | AU | Manufacturing |
|
Genexine, Inc.
Clinical-stage biotech developing long-acting therapeutics …
|
095700 | KR | Manufacturing |
|
Genfit S.A.
Biopharmaceutical firm developing therapies and diagnostics…
|
GNFT | US | Manufacturing |
Lexeo Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33133/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33133 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33133 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33133 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33133}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lexeo Therapeutics, Inc. (id: 33133)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.